Coya Therapeutics, Inc.
Developing Treg-modulating therapies for neurodegenerative and autoimmune diseases.
COYA | US
Overview
Corporate Details
- ISIN(s):
- US22407B1089
- LEI:
- Country:
- United States of America
- Address:
- 12645 MEMORIAL DR., SUITE F1 #305, 77024 HOUSTON
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Coya Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing proprietary therapies that modulate and enhance the function of regulatory T cells (Tregs). The company's multi-modality platform is designed to suppress inflammation and address immune system dysregulation underlying various diseases. Its diversified pipeline includes Treg-enhancing biologics, allogeneic Treg-derived exosomes, and autologous Treg cell therapies. These treatments are being developed to target severe neurodegenerative, autoimmune, and metabolic conditions, with key programs focused on diseases such as Amyotrophic Lateral Sclerosis (ALS), Frontotemporal Dementia, and Alzheimer's disease.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Coya Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Coya Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Coya Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
